Ann: Immutep to present at SITC 2018, page-2

This is 'late' abstact inclusion at SITC as closure date for abstracts is August 1st. Why?

Immutep is also presenting - 'Frederik Triebel speaks on the subject' of TACTI-mel phase 1 results, at the World Immuotheraphy Conference a few days earlier - 31st October. It's a strange one as SITC abstract trial data are not allowed to be published prior to presentation......

'Late-breaking abstract submission is solely for abstracts with late-breaking data and not for abstracts submitted “late.” The late-breaking abstract deadline is not intended to be an extension of the general submission deadline. Late-breaking abstracts highlight novel and practice-changing studies, and only apply to data that would have not otherwise have been presented as an abstract at the 33^rd Annual Meeting.
The data in the abstract must not be published prior to the SITC 33^rd Annual Meeting'.

Therefore suggest detailed data of phase 1 is signifcant enough to qualify at late inclusion at SITC?....imo.